Is Pitolisant-wakix included in medical insurance?

Pitolisant (Pitolisant) -wakix is used to treat adults with excessive daytime sleepiness (EDS) or cataplexy (sudden loss of muscle strength), both of which are symptoms of narcolepsy, a long-term sleep disorder. Tilolixen is thought to work by changing the amount of histamine in areas of the brain that control sleep and wakefulness because it acts on histamine-3 (H3) receptors.

Tilorisen tablets are the only non-controlled drug for the treatment of narcolepsy approved by the U.S. Food and Drug Administration (FDA). It is not a stimulant. Narcolepsy is a disorder that affects the brain's control of sleep-wake cycles. Often people with narcolepsy experience disrupted sleep and may feel very sleepy during the day, which interferes with their daily life. Everyone with narcolepsy has excessive daytime sleepiness, which is when they have an intense feeling of sleepiness that sets in quickly. Cataplexy is when you suddenly lose muscle tone while awake, resulting in muscle weakness and loss of muscle control. Cataplexy can be mild, lasting only a short time, or severe, causing general collapse.

Tilorisen tablets have been launched in China under the trade name Hua Kesi, but they have not yet been included in medical insurance, and the specific domestic price is not yet clear. The original version of tilorisen tablets marketed overseas is sold under the trade name Wakix. It is available in two specifications: 4.45mg*30 and 17.8mg*30. The price of each box may be more than 4,000 yuan (the price may fluctuate due to exchange rates). Currently, there are no generic versions of tilorisen tablets produced and marketed overseas. For more drug information and specific prices, please consult Yaode Medical Consultant.